This program accelerates ambitious startups that develop and deploy therapies based on biotechnologies.
Recent scientific discoveries are taking the biotechnology sector to new levels and into new territories. However, this also creates far-reaching challenges relating to ethics, innovation and regulations. BioTechs are revolutionizing R&D for new therapies and therapeutic processes for caregivers and patients. These solutions have the potential to transform the entire health chain – production, delivery and monitoring – and connect the scientific world to evolving economic realities.